Abstract Sporadic inclusion-body myositis (s-IBM), the most common muscle disease of older persons, is of unknown cause and lacks successful treatment. Here we summarize diagnostic criteria and discuss our current understanding of the steps in the pathogenic cascade. While it is agreed that both degeneration and mononuclear-cell inXammation are components of the s-IBM pathology, how each relates to the pathogenesis remains unsettled. We suggest that the intra-muscle-Wber degenerative component plays the primary role, leading to muscle-Wber destruction and clinical weakness, since anti-inXammatory treatments are not of sustained beneWt. We discuss possible treatment strategies aimed toward ameliorating a degenerative component, for example, lithium and resveratrol. Also discussed are the intriguing phenotypic similarities between s-IBM muscle Wbers and the brains of Alzheimer and Parkinson's diseases, the most common neurodegenerative diseases associated with aging. Similarities include, in the respective tissues, cellular aging, mitochondrial abnormalities, oxidative and endoplasmic-reticulum stresses, proteasome inhibition and multiprotein aggregates.
Introduction
Sporadic inclusion-body myositis (s-IBM) is the most common muscle disease of older persons, age 55-plus. Its course is relentlessly progressive and there is no successful treatment. The s-IBM molecular muscle-Wber phenotype is virtually unique for a muscle disease, in that the pathological abnormalities within muscle Wbers bear a number of strong similarities to Alzheimer's disease (AD) and Parkinson's disease (PD) brains (details below). In our opinion, those abnormalities play crucial roles in the s-IBM pathogenesis; they likely contribute importantly to the muscle-Wber degeneration and atrophy, which ultimately are responsible for the progressive muscle-Wber destruction to cause the relentlessly progressive clinical weakness.
In this article we present our current views on possible mechanisms leading to the characteristic features of s-IBM muscle Wbers. We also present our newest data relevant to our concept that s-IBM is an age-associated disorder. And, we discuss the possible relationship between the degenerative and inXammatory components in s-IBM muscle tissues.
Because s-IBM still remains greatly underdiagnosed, we Wrst present a short summary of the pathological diagnostic criteria that we consider important.
Diagnostic criteria of the s-IBM muscle biopsy

Light-microscopic histochemistry and immunocytochemistry
To diagnose s-IBM, and to help distinguish it from polymyositis, we suggest that the following stainings be performed on 10 m transverse sections of a fresh-frozen muscle biopsy: (1) Engel trichrome staining [36] (Fig. 1a, b) , which reveals several to numerous muscle Wbers containing one or a few vacuoles in a given section, and various degrees of lymphocytic inXammation (with some macrophages). While some of the vacuoles appear rimmed by a trichrome-reddish material (which indicates lipoprotein membranous material [36, 37] ), often the vacuoles do not have a conspicuous reddish rim and appear "empty" (these must be distinguished from freeze-artefacts). (2) Fluorescence-enhanced Congo-red [6] to detect -pleated-sheet amyloid inclusions (Fig. 1c) . Multiple or single foci of amyloid, as identiWed by Congo-red Xuorescence visualized through Texas-red Wlters [6] , are evident within about 60-80% of the s-IBM vacuolated muscle Wbers in a given transverse section, rarely within vacuoles but mostly in their non-vacuolated regions (the seemingly "amyloid-negative" Wbers may have amyloid foci at other levels of those same Wbers). This Xuorescence-enhanced Congo-red technique is the best and most sensitive method for highlighting amyloid inclusions, which sometimes are very small or few. Crystal violet metachromasia staining can also show the intra-myoWber amyloid deposits [35] , more conveniently but much less precisely. Congo-red visualized in polarized light, a widely used amyloid-seeking method, is the least precise and most diYcult to interpret, and should not be used routinely for s-IBM muscle biopsies. (3) Staining with SMI-31 monoclonal antibody, which recognizes phosphorylated tau (p-tau), in Alzheimer's disease (AD) brain and s-IBM muscle [3, 55, 67] , and identiWes squiggly inclusions containing p-tau in in s-IBM muscle Wbers [3, 10] (Fig. 1d) . If SMI-31 antibody is not available, ubiquitin immunoreactivity can be used to identify ubiquitin in both p-tau and A intra-myoWber deposits of s-IBM (Fig. 1e ) [16, 77] . Congo-red Xuorescence, SMI-31 and ubiquitin immunoreactivities diVerentiate s-IBM from polymyositis, which does not have intra-Wber deposits positive with those reactions [10, 35] . (4) Immunostaining for amyloid-beta (A ) (Fig. 1f) is also useful but it is not required to diagnose s-IBM.
There are other light-microscopy aspects of s-IBM muscle biopsies that are characteristic and important, but not diagnostic for s-IBM. Examples are: (1) mitochondrial abnormalities, which include (a) ragged-red Wbers [38] , and (b) cytochrome-c-oxidase (COX) negative muscle Wbers that are more common in s-IBM than expected for the patient's age [68, 79, and below] . (2) Small angular muscle Wbers, which are histochemically dark with the pan-esterase and NADHtetrazolium-reductase reactions. They are always present and are indistinguishable from those in ordinary denervation diseases. Those atrophic Wbers are generally considered indicative of "recent-denervation" [37] , and probably contribute signiWcantly to the clinical weakness [35] .
Ultrastructural abnormalities of s-IBM muscle Wbers
Very characteristic are paired helical Wlaments (PHFs), often in clusters. They strikingly resemble PHFs of AD brain, being 15-21 nm diameter [7, 66] . They are present in both vacuolated and non-vacuolated muscle Wbers (Fig. 2a,  b) [detailed review in 10]. The s-IBM PHFs typically are immunostained with antibodies against phosphorylated tau by both gold-and peroxidase-immuno-electron microscopy ( Fig. 2c, d ). 
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The s-IBM vacuolated muscle-Wber cytoplasm, and often cytoplasm of non-vacuolated muscle Wbers, also contain A -immuno-positive: (a) collections of 6-10 nm Wlaments; (b) Wne Xocculomembranous material; and (c) amorphous material (Fig. 2e, f) [2, 5] . Only A , and neither N-nor C-terminal epitopes of amyloid-precursor protein (A PP), is present on 6-10 nm amyloid-like Wlaments [2] . Myelin-like whorls and other lysosomal debris are present in the vacuolated Wbers. Ultrastructurally abnormal mitochondria containing paracrystalline inclusions are occasionally present but not speciWc for s-IBM muscle Wbers.
Our current concepts of s-IBM pathogenesis
Characteristic features of s-IBM muscle-Wber degeneration
We consider s-IBM essentially a degenerative muscle disease: (a) occurring within an aged muscle cellular environment, (b) associated with intracellular accumulation and aggregation of a number of proteins, (c) in conjunction with oxidative and endoplasmic-reticulum (ER) stresses, and (d) involving abnormal signal transduction and transcription. Those together lead to the IBM-speciWc muscle-Wber degenerative process.
In addition to muscle-Wber vacuolization and atrophy, degenerating s-IBM muscle Wbers are characterized by accumulation of intra-muscle-Wber multiprotein aggregates ("inclusion-bodies"). In a given biopsy cross-section, the aggregates are present mainly in vacuole-free regions of vacuolated muscle-Wber cytoplasm and in cytoplasm of "non-vacuolated" Wbers (because muscle Wbers are individual cells often centimeters long, they might be vacuolated at another level). The vacuoles themselves usually do not contain the IBM-characteristic inclusions [12] . The s-IBM vacuoles are considered autophagic, since they often contain (a) lysosomal membranous debris, which is considered an end result of muscle-Wber destruction, and (b) increased immunoreactivity of some of the lysosomal enzymes [57] . The two major types of aggregates/inclusions in s-IBM muscle Wbers are: (a) the rounded, plaque-like aggregates prominently containing A immunoreactivity, and (b) various-sized delicate, squiggly, linear aggregates containing p-tau, which are PHF by EM [12, 13] . Both types of aggregates contain proteins that are congophilic, indicatingpleated-sheet conWguration of amyloid [12] . And both also contain other proteins having a propensity to misfold, including -synuclein and presenilin1 [4, 8, 12 , also below]. Other characteristic features of the s-IBM muscleWber phenotype are evidence of proteasome inhibition, ER stress, and the unfolded-protein-response (UPR) [41, 72, 103, and below] . Accordingly, we consider that s-IBM is a conformational disease of muscle in which unfolding and misfolding of proteins within muscle Wbers play a major role in cytotoxicity and the formation of multiprotein aggregates [11, 12] . We recently demonstrated activation of NF-B [73] , which also provides important insight into the s-IBM pathogenesis (below). We postulate that the aging cellular milieu in the s-IBM muscle Wber is important in promoting development of the characteristic progressive vacuolar degeneration and over-expression/accumulation of several potentially toxic proteins that may underlie disease progression (details below). Despite a concurrent overexpression of both putatively protective and damaging proteins and mechanisms [13] , the defensive and reparative mechanisms are evidently insuYcient because the muscle Wbers continue to deteriorate and eventually die. Also contributing to progression might be that-compared to other myopathies including polymyositis and dermatomyositisin s-IBM there is a deWnite paucity of regenerating muscle Wbers ( [67] , and Askanas and Engel, personal observations).
Possible relationship between muscle-Wber degeneration and lymphocytic inXammation in s-IBM muscle biopsies Also characteristic component of s-IBM muscle biopsies is a lymphocytic inXammation, mainly composed of cytotoxic CD8 cells [reviewed in 29] . Which component, degenerative or inXammatory, precedes the s-IBM pathogenesis [13, 29, 69 ] is a debated but unresolved issue. An earlier study reported that in cultured muscle cells, A induces expression if IL-6 [17] , supporting a primary, or possibly aggravating, role of A in inducing an immune response. Conversely, a recent study reported that cytokine Il-1 induces A PP in cultured muscle cells [82] , supporting a primary, or perhaps an aggravating, role of inXammation in s-IBM [31] . Another argument given for primacy of the inXammatory component is that s-IBM muscle Wbers abundantly express MHC-1, and muscle Wbers expressing MHC-1 are invaded by clonally expanded cytotoxic CD8 + lymphocytes [29, 30] , as also occurs in polymyositis [29, 30] . However, MHC-1 expression is also present on regenerating muscle Wbers in various other myopathies ( [30] and Paciello and Askanas, unpublished observations, 2005). Moreover, MHC-1 is strongly expressed on non-regenerating muscle Wbers in (a) genetic dysferlin deWciency, where it is associated with CD4 rather than CD8 T-lymphocyte response [21] , and (b) in limb-girdle muscular dystrophy 2-I, where it is accompanied by inXammation [32] . In those two examples, presumably the genetic protein abnormally somehow leads to the MHC-1 expression. While MHC-1 is critical for a muscle Wber to become antigen-presenting, the mechanisms causing MHC-1 expression in s-IBM Wbers are not known. There are several possible mechanisms. One is provocation by the acquired dysconWguration of intramuscle Wber proteins (see below). Or possibly, MHC-1 expression in s-IBM results from the demonstrated ER stress ( [72, 103] , and see below), which additionally might be induced by A PP that associates with ER chaperones GRP78 and GRP94 [103] . It has been shown that binding of ER chaperones to some peptides leads to expression of MHC-1, cellular antigen display, and activation of MHC-restricted T-cells [18, 89, 96] . ER stress recently has been shown to induce inXammatory and autoimmune responses [95, 119] . Very recently, we demonstrated activation of NF-B in s-IBM muscle Wbers [73] since NF-B is a known proinXammatory factor [61] , such NF-B activation might contribute to s-IBM inXammation.
Relevant to treating patients, the main consideration in analyzing the s-IBM pathogenesis should focus less on whether inXammatory features are primary or secondary, and more on which of the pathologic abnormalities lead to muscle-Wber degeneration and weakness. It is now wellaccepted that despite accumulation and activation of T-cells, s-IBM patients as a group respond poorly to anti-dysimmune treatment, in contrast to polymyositis patients, who have virtually identical immunopathologic abnormalities in their muscle biopsies [13, 29, 30, 35, 69] . This suggests that non-inXammatory factors are clinically more important.
We propose that the degenerative component within s-IBM muscle Wbers (see details below) is pathogenically more important and is responsible for lack of response to various immune-modulating treatments. Accordingly, therapeutic considerations should focus on reducing detrimental degenerative components (suggestions below).
Possible detrimental role of various proteins abnormally accumulated within s-IBM muscle Wbers
Intracellular toxicity of A PP/A
We have proposed for several years that increased intracellular expression of A PP and of its proteolytic fragment A play key upstream, toxic roles in the s-IBM pathogenesis [10, 12, 13] . Several experimental studies, including the cultured human muscle IBM-model, and transgenic mouse models, provide strong evidence for an intracellular toxicity of A PP/A in s-IBM (recently reviewed in detail in [13] ). Increased A PP mRNA and abnormal accumulation of both A PP and A are identiWed early in s-IBM abnormal muscle Wbers [10, 12] . In addition, there are abnormalities of the A PP processing machinery. BACE1 and BACE2, which are glycosylated transmembrane -secretases that cleave A PP at the N-terminal of A [49, 62, 86] , are increased in s-IBM muscle Wbers, where they are accumulated in the form of inclusions co-localizing with A [104, 105] . BACE 1 also co-immunoprecipitates with A PP in s-IBM muscle [113] , suggesting that it may participate in A PP processing and abnormal generation of the A there. Nicastrin and presenilins, which are components of the -secretase system that cleaves A PP at the C-terminal of A , generating either A 40 or A 42 (reviewed in [87, 107] ), are also strongly overexpressed in s-IBM muscle Wbers, where they (a) colocalize with each other and with A PP [85, 106] , and (b) are physically associated with A PP in both s-IBM and in experimentally A PP-overexpressing muscle Wbers (Vattemi and Askanas, unpublished observation, 2003). Accordingly, both -and -secretases appear to participate in A production within s-IBM muscle Wbers. This probably would not be a problem if the A would be properly disposed of (see below). A PP/ A overexpressed in regenerating muscle Wbers in various other muscle diseases does not seem to cause diYculty and is not associated with the s-IBM type of muscle-Wber degeneration [80, 105] .Our most recent studies showed that in s-IBM muscle Wbers A PP is phosphorylated [93] , and according to others, phosphorylation of A PP increases its toxicity and assembly into A toxic oligomers [23, 59] . Additionally, in s-IBM muscle Wbers, there is preferential accumulation of the A 42 fragment [101] , which is known to be more hydrophobic and more prone to selfassociation and oligomerization, and as such is much more cytotoxic than A 40 [39, 43, 44, 109] . A cytotoxicity is considerably enhanced by its oligomerization. [39, 43, 44, 109] . In s-IBM muscle Wbers, all congophilic (i.e., Wbrillar, amyloidic) A inclusions contain A 42 (Fig. 3 , and Vattemi and Askanas, unpublished), while only some contain both A 40 and A 42 [101] . There are several other factors acting in s-IBM muscle Wbers that might contribute to A production, deposition and oligomerization. These include increased expression and accumulation of: (1) cystatin C (CC), an endogenous cysteine protease inhibitor, which was previously proposed to participate in A deposition within the amyloid plaques AD brain [102] ; (2) transglutaminases 1a and 2, which contribute to A aggregation and insolubility by cross-linking A molecules [26] , and (3) free cholesterol [51] , which increases A production and amyloidogenesis (referenced in [51] ). Our recent study [112] demonstrated that in s-IBM biopsied muscle and in A PP-overexpressing cultured human muscle Wbers, Bcrystallin ( BC), which speciWcally recognizes and stabilizes proteins that have a propensity to aggregate and precipitate [33, 88, 117] , physically associated with A PP and A oligomers [112] . Therefore, binding of BC to A oligomers conceivably might retard and diminish their Wbrillization and aggregation into visible non-toxic aggregates, thereby adversely prolonging their existence as toxic oligomers, increasing their cytotoxicity [112] (alternatively, that binding of BC conceivably could detoxify A ).
Myostatin
Myostatin (MSTN) is a secreted protein, considered to be a negative regulator of muscle growth during development and of muscle mass during adulthood (reviewed in [52] ). In biopsied s-IBM muscle Wbers, MSTN precursor protein (MSTN-PP) and MSTN dimer were signiWcantly increased; and MSTN-PP was physically associated with A PP, and co-localized with A by light-and electron-microscopic immunocytochemistry [111] . Moreover, A PP-overexpression into cultured normal human muscle Wbers increased MSTN-PP expression, and subsequent experimental inhibition of proteasome caused co-accumulation of both MSTN-PP/MSTN and A PP/A within aggresomes, and their physical association was evident by immunoprecipitation [114] . We proposed that A PP binding to MSTN-PP causes its posttranslational modiWcation that lessens its degradation and traYc, resulting in MSTN-PP accumulation.
Of particular interest are our recent studies demonstrating that in cultured human muscle Wbers MSTN-PP mRNA and MSTN protein are signiWcantly increased by NF-B activation caused by experimentally induced ER stress [73] . The same mechanisms might contribute to the increase of MSTN in s-IBM muscle Wbers, because: (a) ER stress is an important component of the s-IBM pathogenesis, and (b) the activity of NF-B is increased in s-IBM muscle Wbers [73] . Figure 4 illustrates our proposed mechanisms leading to MSTN increase and accumulation in s-IBM muscle Wbers.
-Synuclein ( -syn)
Abnormal expression of -syn occurring spontaneously in brains of various neurodegenerative disorders has been associated with, and possibly causative of, oxidative stress, impaired proteasome function, and mitochondrial abnormalities [20, 27, 46, 63, 98] . We have shown (a) that -syn is accumulated in s-IBM muscle Wbers [4] , and (b) that its 22 kDa O-glycosylated form is more expressed than its native 16 kDa form [76] . The 22 kDa form, but not the native 16 kDa form, was shown by others to be a target of ubiquitination by parkin [85] . The preferential increase of the 22 kDa O-glycosylated form of -syn in s-IBM muscle Wbers might be due to the proteasome inhibition we previously demonstrated in them [41, and below] .
Because oxidative-and nitric-oxide-induced stress, and mitochondrial abnormalities, are also aspects of the s-IBM muscle-Wber pathology (reviewed in [12, 13] ), a putative toxicity of -syn, in addition to the cytotoxicity of A and MSTN, may contribute to the muscle-Wber degeneration.
Parkin
This is an E3-ubiquitin ligase that ubiquitinates -syn [81] . Parkin is increased in s-IBM muscle Wbers, where it accumulates in the form of aggregates or aggresomes [76] . In brains of sporadic PD patients, parkin and -syn accumulate in Lewy bodies, which are considered aggresomes [81] . Parkin, in addition to ubiquitinating several proteins, also protects cells against toxicity induced by -syn, ER and other stresses, perhaps by helping to aggregate toxic -syn oligomers and promote their degradation [50, 97] . Accordingly, we propose that increase of parkin in s-IBM muscle Wbers is their attempt to protect themselves against toxicity induced by -syn, ER and other stresses existing within themselves. However, the 2.7-fold increase of parkin in s-IBM muscle Wbers might not be suYcient to overcome a sixfold increase of -syn [76] , or to protect against other continuing stresses. Accordingly, relative insuYciency of parkin could worsen the course of s-IBM. If so, manipulations toward increasing parkin might clinically beneWt s-IBM muscle. Other important intracellular abnormalities in s-IBM muscle Wbers
Decreased deacetylase activity of SIRT1
SIRT1 belongs to the mammalian sirtuin family of NAD + -dependent histone deacetylases (HDACs) [45, 65, 100, 115] . Targets known to be deacetylated by SIRT1 include histone 4 (H4), NF-B, and p53 [45, 65, 100, 115] . Through its deacetylase activity, SIRT1 is considered to control cellular metabolic homeostasis, and to play an important role in the regulation of gene expression, cell proliferation, diVerentiation, survival and senescence [45, 65, 100, 115] . SIRT1 activation has been considered to play a crucial role in the calorie-restriction (CR)-induced longevity in several species [65] .
In addition, SIRT1 activation has been proposed to play a role in neuroprotection. For example, in an AD mouse model, increase of neuronal SIRT1 and its activation were reported to underlie the calorie-restriction prevention of A -related AD-like neuropathology [78] . In various cell lines, increase of SIRT1 or its activation was reported to protect against A toxicity by either decreasing the amount of A by activating -secretase [78] , or by inhibiting NF-B activation and its subsequent disturbance of signaling [24] .
Our most recent studies have shown that, as compared to age-matched controls, in homogenates of s-IBM muscle Wbers SIRT1 activity and deacetylation of SIRT1 targets NF-B, H4, and p53 were signiWcantly decreased despite increased SIRT1 protein expression [71] . Within isolated s-IBM muscle nuclei, there was decreased SIRT1 deacetylation activity accompanied by decreased SIRT1 protein expression in them [71] . Since increased acetylation (or decreased deacetylation) of NF-B leads to its increased activity [116] , decreased SIRT1 deacetylase activity might be directly responsible for the presumably detrimental NF-B activation in s-IBM muscle Wbers.
Our study provides, to our knowledge, the Wrst demonstration of decreased SIRT1 deacetylase activity in any human muscle disease, viz., s-IBM, which is associated with aging. In well-diVerentiated cultured human muscle Wbers, experimentally induced ER stress decreased SIRT1 activity and consequently increased NF B acetylation (activation) [71] . Accordingly, in s-IBM muscle Wbers, inadequate activity of SIRT1 may be detrimental by increasing NF-B activation, and thereby contributing to the abnormal accumulation of A and increased MSTN. Our proposed important consequences of decreased SIRT1 activity in s-IBM muscle Wbers are illustrated in Fig. 5 .
If correct, improving SIRT1 action by treatment with known SIRT1 activators might beneWt s-IBM patients (see below).
Proteasome inhibition and aggresomes
The 26S proteasome, an about 700 kDa multi-subunit protease complex present in the cytoplasm and nuclei of eukaryotic cells, has a major role in degrading normal and abnormal proteins through a ubiquitin-mediated process [108] . We have reported signiWcant inhibition of the 26S proteasome function in (a) s-IBM muscle Wbers, and (b) cultured human muscle Wbers experimentally overexpressing A /A PP [41] . Aggresomes, which form when the Proposed adverse eVects of decreased SIRT1 deacetylase activity in s-IBM muscle Wbers. Decreased deacetylase activity of SIRT1 activates NF-B by increasing its acetylation (NF-B-Ac). This leads to increased myostatin, and other detrimental consequences. Decreased SIRT1 activity also increases A PP and A , resulting in their known detrimental eVects in s-IBM muscle Wbers, as detailed in the text. Decreased SIRT1 activity might also inhibit autophagy, contributing to the accumulation of multiprotein aggregates proteasome is inhibited (referenced in [41] ), are also part of the s-IBM muscle-Wber phenotype [41] ; they were induced in cultured human muscle Wbers by overexpressing A PP § proteasome inhibition [41] .
In addition to increased A /A PP, other factors such as an aging muscle-Wber environment, protein overcrowding, oxidative stress, and accumulated p-tau, -synuclein, and UBB +1 (referenced in [41] and below) might contribute to proteasome inhibition in s-IBM muscle Wbers, resulting in accumulation of aggregated misfolded proteins into aggresomes. Furthermore, the unfolded/misfolded proteins might, in the putatively susceptible s-IBM patients, elicit expression and presentation of MHC-1 by the muscle Wber, and consequently induce a secondary CD8 T-cell response (see above).
Molecular misreading and accumulation of mutated ubiquitin (UBB +1 )
"Molecular misreading" involves acquired, non-DNAencoded dinucleotide deletions occurring within mRNAs, resulting in production of potentially toxic mutant proteins (recently reviewed in [99] ). The aberrant transcripts are formed as a result of dinucleotide loss ( GA, GU) during or after transcription, and they can be translated from the deletion onward into the +1 reading-frame to produce abnormal proteins, e.g., mutant ubiquitin, termed UBB +1 . The UBB +1 protein was shown to be accumulated in the dystrophic neurites as a component of neuritic plaques, and in neuroWbrillary tangles of AD brain [99] , as well as in brains of other neurodegenerative disorders in which inhibition of the proteasome has been proposed to play a pathogenic role [99] . The UBB +1 itself can become ubiquitinated, and then that form can inhibit the proteasome [99] .
In s-IBM muscle Wbers, UBB +1 was shown as being accumulated in the form of aggregates, providing the Wrst demonstration that molecular misreading can occur in diseased human muscle [42] . We suggested that the aging cellular environment of s-IBM muscle Wbers, combined with factors such as oxidative stress and perhaps other detrimental molecular events, leads to abnormal production and accumulation of UBB +1 [42] . Moreover, a high level of UBB +1 inhibits the 26S proteasome [99] , and this mechanism might contribute to proteasome inhibition in s-IBM muscle Wbers.
Endoplasmic-reticulum stress and the UPR
The ER is an intracellular compartment having a critical role in the processing, folding and exporting of newly synthesized proteins into the secretory pathway (reviewed in [95, 118, 119] ). In the ER, molecular chaperones are required to assure proper folding of unfolded or misfolded proteins [95, 118, 119] . Unfolded proteins accumulating in the ER cause ER stress [95, 118, 119] . This elicits the UPR, a functional mechanism by which a cell attempts to protect itself against ERS [95, 118, 119] . In s-IBM muscle Wbers, we have previously reported evidence of ER stress and the UPR [72, 103] . Recently, we demonstrated that in cultured normal human muscle Wbers experimentally produced ER stress (a) induces MSTN through an NF-B-related mechanism, and (b) decreases SIRT1 deacetylase activity (see above and [71, 73] ). Accordingly, ER stress may importantly contribute to the s-IBM pathogenesis.
Mitochondrial abnormalities
These include: (a) ragged-red Wbers [38] , (b) cytochrome-coxidase (COX) negative muscle Wbers, and (c) multiple mitochondrial DNA deletions (reviewed in [68, 74, 75] ). These are more common in s-IBM muscle than expected for the patient's age [75, 79] . Our newest studies conWrmed that COX-negative muscle Wbers are signiWcantly increased in s-IBM muscle biopsies and, although the COX-negative Wbers are 90% Type-II, there is more involvement of Type-I Wbers than in controls [91] . Our morphologically determined total percent of "COX-negative Wbers" on transverse sections probably greatly underestimates their actual number because on longitudinal view the regions of COX-negativity are segmentally multifocal along the Wbers ( [75] ; our unpublished observation). Although we previously showed in our IBM-model that excessive A PP and A contribute to the mitochondrial abnormalities [15] (a concept now supported by studies in other systems, especially as putatively related to AD and Parkinson's brain ( [1, 46, 47] and referenced in [93] ), our recent studies showed that COXnegative Wbers do not preferentially contain aggregated A and p-tau [91] and, as also recently reported [22] , they do not correlate with foci of mononuclear inXammatory cells [91] . Accordingly, other yet unknown mechanisms seem to be causing the prominent COX-negativity in s-IBM muscle Wbers. Possibilities include: toxic unaggregated oligomers of A , -syn, or other proteins; and factors resulting from oxidative or ER stresses. Discovery of their cause could facilitate developing treatment strategies. The mitochondrial abnormalities presumably contribute to the muscleWber malfunction and degeneration.
In the seemingly otherwise-intact muscle Wbers, regions of COX-negativity cannot make ATP via oxidative-phosphorylation; those presumably weakened regions must be surviving on ATP diVusing from adjacent COX-positive regions or produced by anaerobic glycolysis.
DJ-1
The Parkinson-disease-related DJ-1 is a ubiquitously expressed protein of the ThiJ/PfpI/DJ1 superfamily (reviewed in [19, 25, 90] and referenced in [94] ). We recently reported that DJ-1 is increased in s-IBM muscle Wbers, where it is (a) highly oxidized and (b) abnormally accumulated in muscle-Wber mitochondria [94] . Mutations in the DJ-1 gene that prevent expression of DJ-1 protein are a cause of early-onset autosomal-recessive PD [19, 25, 90] . In sporadic AD and PD brains, DJ-1 was reported to be increased and highly oxidized [25] . Although its precise functions are not yet known, DJ-1 has been proposed to act as an antioxidant ( [90] and referenced in [94] ) and be an important mitochondrial protective agent (referenced in [94] ). Increased oxidation of DJ-1 itself was proposed to decrease its anti-oxidant activity ( [90] and referenced in [94] ). We suggest that in s-IBM muscle Wbers the increased DJ-1 may be attempting to mitigate mitochondrial and oxidative damage, but its being excessively oxidized may render it ineVective [94] .
Possible treatment avenues for s-IBM
Based on our studies, we propose that the most important general approach to developing treatment for s-IBM patients or to prevent progression of the disease is to stop deterioration and atrophy of the muscle Wbers. The treatment approaches might be multifactorial, aiming toward various detrimental factors described above. Some approaches, based on our experimental IBM-culture models, appear promising. For example, our most recent studies demonstrated the following.
Resveratrol
Treatment with resveratrol of ER stress-induced cultured human muscle Wbers (ER stress + IBM-culture-model) signiWcantly decreased in them myostatin mRNA and protein, and was associated NF-B de-acetylation (de-activation) [70] . Previously, resveratrol was shown to decrease A and diminish AD neuropathology in AD mouse models [reviewed in 28] . Resveratrol (trans-3,4Ј,5-trihydroxystilbene), is an antioxidant polyphenol and a potent activator of SIRT1 (reviewed in [27] ). Accordingly, resveratrol, and/ or other small molecules that activate SIRT1, activity of which is decreased in s-IBM muscle [71] , might be beneWcial in treating s-IBM patients. Recently, SIRT1 activity has been reported to increase autophagy [60] . Although the exact role of autophagy in s-IBM awaits further studies, resveratrol possibly could also beneWt s-IBM patients through induction of autophagy.
Lithium
Lithium has previously been shown to diminish tau and A pathologies in various experimental models of AD (reviewed in [34] ), but its clinical eYcacy in treating AD patients is not established. In a transgenic mouse model whose skeletal muscle bears some aspects of IBM muscle Wbers, lithium was reported to decrease tau phosphorylation through decreasing activity of GSK-3 [54] .
Recently, we have shown that treatment of A PP-overexpressing cultured human muscle Wbers (A PP + culture-IBM-model) with lithium signiWcantly decreased total A PP, phosphorylated A PP, and A oligomers [92] . In addition, lithium signiWcantly increased the inactive form of GSK-3 and increased expression of an autophagosome marker LC3-II [92] . Accordingly, treating of s-IBM patients with lithium possibly could be beneWcial.
Other possible treatments
Other approaches may involve the following. (1) Stopping hyper-phosphorylation of tau, which leads to its self-aggregation into PHFs, or blocking the aggregation process itself (and blocking any hypothetical binding of hyper-phosphorylated tau to normal cellular components). (2) Diminishing adverse eVects of intra-muscle Wber cholesterol. However, the use of statins is of uncertain beneWt and potentially myotoxic. 
Intriguing similarities of the s-IBM muscle Wber phenotype to those of brains of AD and PD
Similarities to the AD brain include accumulation of A , phosphorylated tau (p-tau) and more than 15 other Alzheimer-characteristic proteins [8, 10, 12, 13] . For years it was considered that the extracellular A is exerting the main toxic, detrimental role in AD brain [83, 84] . However, more than a decade ago we proposed that our demonstrated intracellular increase and toxicity of A PP and of its proteolytic fragment A play the key cytotoxic role in the s-IBM pathogenic cascade [14, 15] ; furthermore, we postulated that the same intracellular toxicity might be occurring in the AD pathogenesis [9] . This proposal regarding AD now seems to be gaining momentum, because more and more AD researchers discuss the possible importance of intracellular A accumulation and toxicity in the AD pathogenesis [reviewed in 43, 58] .
Interestingly, there are also phenotypic similarities of s-IBM muscle Wbers to the PD brain, such as accumulation of -syn, parkin and abnormalities of DJ-1, the latter also being present in AD brain [25] . These similarities suggest that the degenerative muscle and the brain diseases may share certain pathogenic steps and that knowledge of one disease might help elucidate the causes and treatments of the others. IBM, AD, and PD, including sporadic and hereditary forms of each, are all multifactorial and polygenetic. The respective cascade of events in each leading to their similar pathologic aspects is not well understoodcellular aging, protein misfolding, aggregation, proteasome inhibition, and mitochondrial abnormalities, as well as oxidative and ER stress have been proposed to be contributing in s-IBM, AD and PD [above, and reviewed in 1, 40, 48, 53, 56, 64, 74, 110] . Yet each disease category remains tissue-and region-speciWc, involving postmitotic-muscle Wbers or postmitotic-neurons, thereby indicating that the mechanism of cellular-targeting is diVerent in IBM, AD and PD. The tissue aVected, muscle versus brain, may be inXuenced by: (1) etiologic agent (? a virus), (2) previous exposure to an environmental factor(s), (3) subtle diVerences of deWciency or toxicity factors, and (4) the patient's genetic background (the cellular microclimate). Easier availability of s-IBM patients' muscle biopsies, as compared to brain tissue, and the possibility of producing IBM experimental models by utilizing cultured human muscle Wbers (which are the cells actually aVected in the s-IBM disease process), might provide better understanding of some pathogenic aspects, not only related to s-IBM, but also to AD and PD, and facilitate development of treatments.
